Search peptides, terms, sources/
Research source · 2023

Efficacy and Safety of Elamipretide in Individuals With Primary Mitochondrial Myopathy: The MMPOWER-3 Randomized Clinical Trial

About this source

Kind
Research
Design
Human clinical trial, RCT
Population
218 adults with genetically confirmed primary mitochondrial myopathy
Sample size
218
Primary or secondary
primary
Peer review
peer reviewed
Retraction status
None known
Date checked
14 November 2026

Limitations

The trial's primary endpoints were not met, so it does not support a benefit in this population. Funder not checked. Abstract read via Europe PMC; full text not read.

Cited in

Spotted an error? Report a problem with this page. We correct the record and log every change on What's changed.